Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01662869
Title A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic HER2-Negative And Met-Positive Gastroesophageal Cancer (MetGastric)
Recruitment Completed
Gender
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Onartuzumab

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.